Imaginis.com was selected as a winner in the Fall/Winter 2007 World Wide Web Health Awards. This program recognizes the best health information Web sites for consumers and professionals, as is coordinated by the Health Information Resource Center, a national clearinghouse for consumer health information programs and materials. Imaginis.com received “A SILVER” award in the patient education information category. The award was announced in March 2008.

Tamoxifen is the most commonly used drug to treat breast cancer, but new research suggests that another drug, Femara, may help decrease the risk of a breast cancer recurrence in women who have already taken tamoxifen. The study found that Femara, generic name letrozole, reduce the risk that breast cancer would return in women by about 63 percent, if the women first completed a five-year regimen of tamoxifen. The research sheds light on another treatment that could help successfully fight breast cancer.

Cancer patients and survivors may be at increased risk of bone fractures. Studies have shown, for example, that breast cancer survivors tend to have lower bone density compared to healthy women. In addition, a recent study sponsored in part by the National Institute of Arthritis and Musculoskeletal and Skin Diseases found that breast cancer survivors may be at an increased risk for bone fractures. This may be because some breast cancer treatments may weaken bones. Being diagnosed and treated with cancer can also lead to physical inactivity, which puts women at greater risk of fracture. Learn more about how bone fractures occur and how they can be treated, including a promising new treatment called balloon kyphoplasty.

Coronary artery disease is the most common form of heart disease in America and Europe and is a serious health problem worldwide. CAD usually results from atherosclerosis, a condition that occurs when arteries become narrow and hardened due to cholesterol plaque build-up. Patients with CAD are at increased risk of heart attack. This article provides information about heart disease risk factors, diagnosis, and treatment.